MedPath
HSA Product

NEODOL-K TABLET 50 mg

Product approved by Health Sciences Authority (SG)

Basic Information

NEODOL-K TABLET 50 mg

TABLET, SUGAR COATED

Regulatory Information

SIN10619P

January 7, 1999

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XM01AB05

Company Information

Micro Labs Limited

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Active Ingredients

DICLOFENAC POTASSIUM

Strength: 50 mg

Detailed Information

Contraindications

**CONTRAINDICATIONS:** Diclofenac Potassium is contraindicated in patients with hypersensitivity to Diclofenac. Diclofenac Potassium should not be given to patients who have experienced asthma, urticarial, or other allergic-type reactions after taking aspirin or other Non Steroidal Anti-inflammatory Drugs. Severe, rarely fatal, anaphylactic-like reactions to Diclofenac have been reported in such patients. The use of high dose diclofenac (150mg/day) for more than 4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.

Indication Information

**INDICATIONS AND USES:** Diclofenac Potassium is indicated for acute and chronic treatment of signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Diclofenac Potassium is indicated for the management of pain and primary dysmenorrhea.

© Copyright 2025. All Rights Reserved by MedPath